|
Index of reports
> Cases with Drug Interaction (15)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Lidocaine where reactions include drug interaction. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Lidocaine side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-09
Patient: 58 year old male
Reactions: Blood Pressure Increased, Heart Rate Decreased, Drug Interaction, Hypertensive Crisis
Drug(s) suspected as cause:
Lidocaine
Other drugs received by patient possibly interacting with the suspect drug:
Epinephrine
Dosage: 0.04 mg, unk
Propranolol
Dosage: 20 mg, tid
Indication: Hypertension
Possible Lidocaine side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-09
Patient: 52 year old female
Reactions: Blood Pressure Increased, Drug Interaction, Cardiac Arrest, Hypertensive Crisis
Drug(s) suspected as cause:
Lidocaine
Other drugs received by patient possibly interacting with the suspect drug:
Propranolol
Dosage: 40 mg, bid
Epinephrine
Dosage: 0.065 mg, unk
Possible Lidocaine side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States Minor Outlying Islands on 2012-07-09
Patient: 66 year old female
Reactions: Blood Pressure Increased, Heart Rate Increased, Drug Interaction, Hypertensive Crisis
Drug(s) suspected as cause:
Lidocaine
Other drugs received by patient possibly interacting with the suspect drug:
Propranolol
Dosage: 10 mg, bid
Indication: Hypertension
Epinephrine
Dosage: 0.20 mg, unk
Possible Lidocaine side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-09
Patient: 61 year old female
Reactions: Blood Pressure Increased, Heart Rate Decreased, Drug Interaction, Hypertensive Crisis
Drug(s) suspected as cause:
Lidocaine
Other drugs received by patient possibly interacting with the suspect drug:
Epinephrine
Dosage: 0.10 mg, unk
Propranolol
Dosage: 40 mg, bid
Possible Lidocaine side effects in 55 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-09
Patient: 55 year old female
Reactions: Blood Pressure Increased, Heart Rate Decreased, Drug Interaction, Hypertensive Crisis
Drug(s) suspected as cause:
Lidocaine
Other drugs received by patient possibly interacting with the suspect drug:
Propranolol
Dosage: 40 mg, bid
Indication: Migraine Prophylaxis
Epinephrine
Dosage: 0.12 mg, unk
Possible Lidocaine side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-09
Patient: 52 year old female
Reactions: Blood Pressure Increased, Heart Rate Decreased, Drug Interaction, Hypertensive Crisis
Drug(s) suspected as cause:
Lidocaine
Other drugs received by patient possibly interacting with the suspect drug:
Epinephrine
Dosage: 0.20 mg, unk
Propranolol
Dosage: 20 mg, tid
Indication: Hypertension
Possible Lidocaine side effects in female
Reported by a consumer/non-health professional from France on 2012-06-29
Patient: female
Reactions: Abdominal Pain, Weight Decreased, Urinary Incontinence, Blood Count Abnormal, Headache, Loss of Consciousness, Palpitations, Feeling Hot, Ingrowing Nail, Gallbladder Disorder, Nervousness, Anaemia, Hypoaesthesia, Gastric Disorder, Convulsion, Insomnia, Cholecystectomy, Platelet Count Decreased, Drug Ineffective, Blood Triglycerides Increased, Drug Interaction, Micturition Frequency Decreased, Fall, Arterial Occlusive Disease, Dizziness, TOE Operation, Kidney Infection, Blood Pressure Increased, Lung Neoplasm, Cystitis, Arteriogram Coronary Abnormal, Full Blood Count Decreased, Burning Sensation, Carbuncle, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Hydrochlorothiazide
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2011-03-07
Toprol-XL
Dosage: 25 mg/day
Administration route: Oral
Indication: Heart Rate Abnormal
Norvasc
Dosage: 2.5 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 1994-01-01
Dilantin
Dosage: unk
Indication: Convulsion
Start date: 1995-01-01
Xanax
Dosage: 0.5 mg/day
Indication: Product Used FOR Unknown Indication
Furosemide
Dosage: 20 mg, unk
Indication: Product Used FOR Unknown Indication
Lisinopril
Dosage: unk
Indication: Product Used FOR Unknown Indication
Ciprofloxacin HCL
Dosage: unk
Indication: Product Used FOR Unknown Indication
Nopalea
Dosage: unk
Indication: Musculoskeletal Pain
Start date: 2010-01-01
Cardizem
Dosage: unk
Indication: Product Used FOR Unknown Indication
Avapro
Dosage: unk
Indication: Hypertension
Macrobid
Dosage: unk
Indication: Product Used FOR Unknown Indication
Benicar
Dosage: unk
Administration route: Oral
Indication: Hypertension
Start date: 2007-01-01
Reglan
Dosage: unk
Indication: Product Used FOR Unknown Indication
Lidocaine
Dosage: unk
Indication: Anaesthesia
Start date: 2010-05-13
End date: 2010-05-13
Nopalea
Indication: Blood Triglycerides Increased
Diovan
Dosage: unk
Indication: Product Used FOR Unknown Indication
Atacand
Dosage: 32 mg, unk
Administration route: Oral
Indication: Renal Disorder
Start date: 1995-01-01
Bactrim
Dosage: unk
Indication: Product Used FOR Unknown Indication
Toprol-XL
Indication: Flushing
Nebivolol
Dosage: unk
Indication: Product Used FOR Unknown Indication
Norvasc
Dosage: 0.5 mg, unk
Administration route: Oral
Norvasc
Dosage: 2.5 mg, unk
Administration route: Oral
Start date: 2010-07-19
End date: 2010-07-21
Norvasc
Dosage: 0.5 mg, unk
Administration route: Oral
Start date: 2010-07-22
Norvasc
Dosage: 5 mg, bid
Administration route: Oral
Start date: 2010-01-01
Furosemide
Dosage: unk
Losartan Potassium
Dosage: unk
Indication: Product Used FOR Unknown Indication
Depakote
Dosage: unk
Indication: Convulsion
Start date: 1995-01-01
End date: 2004-01-01
Norvasc
Dosage: 5 mg/day
Administration route: Oral
End date: 1997-01-01
Levaquin
Dosage: unk
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Nitroglycerin; Clonidine; Metoprolol Succinate; Ascorbic Acid; Levothyroxine Sodium
Possible Lidocaine side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-28
Patient: female, weighing 63.6 kg (139.8 pounds)
Reactions: Abdominal Pain, Weight Decreased, Urinary Incontinence, Blood Count Abnormal, Headache, Loss of Consciousness, Palpitations, Feeling Hot, Ingrowing Nail, Gallbladder Disorder, Nervousness, Anaemia, Hypoaesthesia, Gastric Disorder, Convulsion, Insomnia, Cholecystectomy, Platelet Count Decreased, Drug Ineffective, Blood Triglycerides Increased, Drug Interaction, Micturition Frequency Decreased, Fall, Dizziness, Arterial Occlusive Disease, Kidney Infection, TOE Operation, Blood Pressure Increased, Lung Neoplasm, Arteriogram Coronary Abnormal, Cystitis, Full Blood Count Decreased, Haemoglobin Decreased, Burning Sensation, Carbuncle, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ciprofloxacin Hydrochloride
Indication: Product Used FOR Unknown Indication
Nopalea (Plant Alkaloids and Other Natural Products)
Indication: Arthralgia
Start date: 2010-01-01
Furosemide
Indication: Product Used FOR Unknown Indication
Amlodipine Besylate
Administration route: Oral
Start date: 1997-01-01
Nebivolol Hydrochloride
Indication: Product Used FOR Unknown Indication
Depakote
Indication: Convulsion
Start date: 1995-01-01
End date: 2004-01-01
Hydrochlorothiazide
Indication: Product Used FOR Unknown Indication
Start date: 2011-03-07
Avapro
Indication: Hypertension
Atacand
Dosage: 32mg daily
Administration route: Oral
Indication: Renal Disorder
Start date: 1995-01-01
Atacand
Administration route: Oral
Start date: 2011-09-01
Benicar
Dosage: film-coated
Administration route: Oral
Indication: Hypertension
Start date: 2007-01-01
Lisinopril
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Nopalea (Plant Alkaloids and Other Natural Products)
Indication: Blood Triglycerides Increased
Furosemide
Amlodipine Besylate
Administration route: Oral
Start date: 2010-01-01
Cardizem
Dosage: extended release
Indication: Product Used FOR Unknown Indication
Reglan
Indication: Product Used FOR Unknown Indication
Amlodipine Besylate
Administration route: Oral
Start date: 2010-07-19
End date: 2010-07-21
Xanax
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Phenytoin
Indication: Convulsion
Start date: 1995-01-01
Toprol-XL
Indication: Flushing
Amlodipine Besylate
Administration route: Oral
Amlodipine Besylate
Administration route: Oral
Start date: 2010-07-22
Macrobid
Indication: Product Used FOR Unknown Indication
Valsartan
Indication: Product Used FOR Unknown Indication
Lidocaine
Indication: Ingrowing Nail
Start date: 2010-05-13
End date: 2010-05-13
Lidocaine
Indication: Anaesthesia
Toprol-XL
Dosage: 25mg daily
Administration route: Oral
Indication: Heart Rate Abnormal
Losartan Potassium
Indication: Product Used FOR Unknown Indication
Bactrim
Indication: Product Used FOR Unknown Indication
Atacand
Levaquin
Indication: Product Used FOR Unknown Indication
Amlodipine Besylate
Administration route: Oral
Indication: Hypertension
Start date: 1994-01-01
Other drugs received by patient: Levothyroxine Sodium; Clonidine; Metoprolol Succinate; Clonidine
Possible Lidocaine side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-19
Patient: female, weighing 63.6 kg (139.8 pounds)
Reactions: Abdominal Pain, Weight Decreased, Urinary Incontinence, Blood Count Abnormal, Headache, Loss of Consciousness, Palpitations, Feeling Hot, Ingrowing Nail, Gallbladder Disorder, Nervousness, Anaemia, Hypoaesthesia, Gastric Disorder, Convulsion, Insomnia, Platelet Count Decreased, Cholecystectomy, Drug Ineffective, Blood Triglycerides Increased, Drug Interaction, Micturition Frequency Decreased, Fall, Dizziness, Arterial Occlusive Disease, TOE Operation, Kidney Infection, Blood Pressure Increased, Lung Neoplasm, Arteriogram Coronary Abnormal, Cystitis, Full Blood Count Decreased, Burning Sensation, Haemoglobin Decreased, Carbuncle, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Phenytoin
Indication: Convulsion
Ciprofloxacin Hydrochloride
Indication: Product Used FOR Unknown Indication
Lidocaine
Indication: Ingrowing Nail
Start date: 2010-05-13
End date: 2010-05-13
Valsartan
Indication: Product Used FOR Unknown Indication
Nopalea (Plant Alkaloids and Other Natural Products)
Indication: Arthralgia
Start date: 2010-01-01
Furosemide
Benicar
Dosage: film-coated
Administration route: Oral
Indication: Hypertension
Start date: 2007-01-01
Amlodipine Besylate
Administration route: Oral
Start date: 2010-01-01
Lisinopril
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Depakote
Indication: Convulsion
Start date: 1995-01-01
End date: 2004-01-01
Atacand
Administration route: Oral
Indication: Renal Disorder
Start date: 2011-09-01
Hydrochlorothiazide
Indication: Product Used FOR Unknown Indication
Start date: 2011-03-07
Levaquin
Indication: Product Used FOR Unknown Indication
Amlodipine Besylate
Administration route: Oral
Indication: Hypertension
Start date: 1994-01-01
Amlodipine Besylate
Dosage: film coated
Administration route: Oral
Start date: 2010-07-22
Reglan
Indication: Product Used FOR Unknown Indication
Lidocaine
Indication: Anaesthesia
Toprol-XL
Indication: Flushing
Furosemide
Indication: Product Used FOR Unknown Indication
Avapro
Indication: Hypertension
Amlodipine Besylate
Dosage: film coated
Administration route: Oral
Amlodipine Besylate
Dosage: film coated
Administration route: Oral
Start date: 2010-07-19
End date: 2010-07-21
Losartan Potassium
Indication: Product Used FOR Unknown Indication
Macrobid
Indication: Product Used FOR Unknown Indication
Bactrim
Indication: Product Used FOR Unknown Indication
Toprol-XL
Administration route: Oral
Indication: Heart Rate Abnormal
Nopalea (Plant Alkaloids and Other Natural Products)
Indication: Blood Triglycerides Increased
Atacand
Dosage: daily
Administration route: Oral
Indication: Hypertension
Start date: 1995-01-01
End date: 2011-03-01
Xanax
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cardizem
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Nebivolol Hydrochloride
Indication: Product Used FOR Unknown Indication
Amlodipine Besylate
Administration route: Oral
Start date: 1997-01-01
Other drugs received by patient: Metoprolol Succinate; Clonidine; Clonidine; Levothyroxine Sodium
Possible Lidocaine side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-15
Patient: female, weighing 68.0 kg (149.7 pounds)
Reactions: Weight Decreased, Drug Ineffective, Drug Interaction, Blood Count Abnormal, Headache, Fall, Loss of Consciousness, Palpitations, Feeling Hot, Ingrowing Nail, Dizziness, TOE Operation, Cystitis, Arteriogram Coronary Abnormal, Gastric Disorder, Convulsion, Full Blood Count Decreased, Burning Sensation, Cholecystectomy, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lidocaine
Other drugs received by patient possibly interacting with the suspect drug:
Ciprofloxacin
Dosage: unk
Reglan
Dosage: unk
Norvasc
Dosage: 5 mg, daily
Start date: 1997-01-01
Xanax
Dosage: 1/2 tablet qd
Depakote
Dosage: unk
Indication: Convulsion
Start date: 1995-01-01
End date: 2004-01-01
Toprol-XL
Indication: Flushing
Macrobid
Dosage: unk
Bactrim
Dosage: unk
Atacand
Dosage: 32 mg, 1x/day
Indication: Renal Disorder
Start date: 1995-01-01
Levaquin
Dosage: unk
Dilantin
Dosage: unk
Indication: Convulsion
Start date: 1995-01-01
Furosemide
Lisinopril
Dosage: unk
Losartan Potassium
Dosage: unk
Benicar
Dosage: unk
Indication: Hypertension
Avapro
Dosage: unk
Indication: Hypertension
Hydrochlorothiazide
Dosage: unk
Nebivolol
Dosage: unk
Norvasc
Dosage: 2.5 mg, 1x/day
Indication: Hypertension
Start date: 1994-01-01
Norvasc
Dosage: 5 mg, 2x/day
Start date: 2010-01-01
Cardizem
Dosage: unk
Valsartan
Dosage: unk
Toprol-XL
Dosage: 25 mg, daily
Indication: Heart Rate Abnormal
Other drugs received by patient: Levothyroxine Sodium; Clonidine
Possible Lidocaine side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-12
Patient: female, weighing 68.0 kg (149.7 pounds)
Reactions: Weight Decreased, Blood Count Abnormal, Drug Interaction, Headache, Erythema, Loss of Consciousness, Myocardial Calcification, Palpitations, Dizziness, Ingrowing Nail, Abdominal Distension, TOE Operation, Blood Pressure Increased, Cystitis, Burning Sensation, Insomnia, Cholecystectomy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xanax
Dosage: (1/2 tablet qd)
Indication: Product Used FOR Unknown Indication
Macrobid
Indication: Product Used FOR Unknown Indication
Diovan
Indication: Product Used FOR Unknown Indication
Lidocaine
Indication: Anaesthesia
Start date: 2010-05-13
End date: 2010-05-13
Losartan Potassium
Indication: Product Used FOR Unknown Indication
Cardizem
Indication: Product Used FOR Unknown Indication
Reglan
Indication: Product Used FOR Unknown Indication
Furosemide
Indication: Product Used FOR Unknown Indication
Benicar
Dosage: per oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-01-01
Bactrim
Indication: Product Used FOR Unknown Indication
Hydrochlorothiazide
Indication: Product Used FOR Unknown Indication
Bystolic
Indication: Product Used FOR Unknown Indication
Avapro
Indication: Hypertension
Norvasc
Dosage: 2.5 mg (2.5 mg, qd), oral 5 mg (5 mg, qd), oral 10 mg, (5 mg, bid), oral
Administration route: Oral
Indication: Hypertension
Start date: 1994-01-01
Norvasc
Dosage: 2.5 mg (2.5 mg, qd), oral 5 mg (5 mg, qd), oral 10 mg, (5 mg, bid), oral
Administration route: Oral
Indication: Hypertension
Start date: 1997-01-01
Norvasc
Dosage: 2.5 mg (2.5 mg, qd), oral 5 mg (5 mg, qd), oral 10 mg, (5 mg, bid), oral
Administration route: Oral
Indication: Hypertension
Start date: 2010-01-01
Lisinopril
Indication: Product Used FOR Unknown Indication
Levaquin
Indication: Product Used FOR Unknown Indication
Atacand
Dosage: 32 mg (32 mg)
Indication: Renal Disorder
Start date: 1995-01-01
Ciprofloxacin
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Levothyroxine Sodium; Toprol (Metoprolol Succinate) (Metoprolol Succinate); Clonidine
Possible Lidocaine side effects in male
Reported by a physician from United States on 2012-04-02
Patient: male, weighing 2.4 kg (5.3 pounds)
Reactions: Metabolic Acidosis, Ventricular Arrhythmia, Drug Interaction, Atrioventricular Block, Toxicity To Various Agents, Sinus Bradycardia, Long QT Syndrome Congenital
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lidocaine
Dosage: 1 mg/kg; 10 ug/kg; 40 ug/kg; 1 mg/kg;2 times; 50 ug/kg; 1 mg/kg; iv
Indication: Ventricular Tachycardia
Amiodarone HCL
Dosage: 1 mg/kg; 3 mg;11 times; 1 mg/kg;3 times;
Indication: Torsade DE Pointes
Phenytoin
Dosage: 8 mg/kg; 5 mg/kg;
Indication: Ventricular Tachycardia
Other drugs received by patient: Potassium; Dopamine HCL; Vecuronium Bromide; Fentanyl Citrate; Magnesium; Calcium Gluconate; 5% Albumin; Esmolol HCL; Milrinone; Isoproterenol HCL
Possible Lidocaine side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-22
Patient: male, weighing 2.0 kg (4.4 pounds)
Reactions: Neurotoxicity, Drug Interaction, Toxicity To Various Agents
Drug(s) suspected as cause:
Dopamine HCL IN 5% Dextrose
Indication: Positive Cardiac Inotropic Effect
Milrinone Lactate IN 5% Dextrose Injection IN Plastic Container
Indication: Cardiac Output Decreased
Brevibloc
Brevibloc
Brevibloc
Isoproterenol HCL
Indication: Heart Rate Decreased
Lidocaine
Indication: Ventricular Arrhythmia
Brevibloc
Indication: Ventricular Arrhythmia
Brevibloc
Other drugs received by patient possibly interacting with the suspect drug:
Phenytoin
Nexterone
Indication: Torsade DE Pointes
Nexterone
Lidocaine HCL
Indication: Ventricular Arrhythmia
Lidocaine HCL
Lidocaine HCL
Phenytoin
Indication: Ventricular Tachycardia
Other drugs received by patient: Calcium Gluconate; Magnesium; Albutein; Vecuronium Bromide; Potassium Chloride; Fentanyl
Possible Lidocaine side effects in
Reported by a individual with unspecified qualification from United States on 2012-02-16
Patient:
Reactions: Movement Disorder, Areflexia, Drug Interaction, Pupil Fixed, Toxicity To Various Agents
Drug(s) suspected as cause:
Lidocaine
Dosage: 1mg/kg
Indication: Ventricular Tachycardia
Esmolol HCL
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Albumin (Albumin) (Albumin); Milrinone (Milrinone) (Milrinone); Amiodarone HCL; Vecuronium (Vecuronium) (Vecuronium); Dopamine (Dopamine) (Dopamine); Fentanyl; Calcium Gluconate; Potassium (Potassium) (Potassium); Magnesium (Magnesium) (Magnesium)
Possible Lidocaine side effects in
Reported by a individual with unspecified qualification from United States on 2012-02-01
Patient:
Reactions: Movement Disorder, Drug Interaction, Areflexia, Pupil Fixed
Drug(s) suspected as cause:
Esmolol (Esmolol) (Esmolol)
Indication: Product Used FOR Unknown Indication
Lidocaine
Dosage: 1mg/kg
Indication: Ventricular Tachycardia
Other drugs received by patient: Vecuronium (Vecuronium) (Vecuronium); Milrinone (Milrinone) (Milrinone); Albumin (Albumin) (Albumin); Calcium Gluconate; Magnesium (Magnesium) (Magnesium); Potassium (Potassium) (Potassium); Fentanyl; Dopamine (Dopamine) (Dopamine); Amiodarone HCL
|
